Data / Form D filings / AskY Therapeutics, Inc.
AskY Therapeutics, Inc.: Form D filings
AskY Therapeutics, Inc., a biotechnology company in Owings Mills, MD, filed 2 Form D notices with the SEC between 2023 and 2024. The latest, on June 4, 2024, reports $460,000 sold of a $1.5 million offering to 12 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 12405 Hunters Glen, Owings Mills, MD, 21117
- Phone
- (713) 715-6820
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1962108
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 4, 2024 | New notice | $1,500,000 | $460,000 | $1,040,000 | 12 | May 21, 2024 | sec.gov |
| Jan 17, 2023 | New notice | $500,000 | $280,000 | $220,000 | 10 | Dec 2, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Alexander Krupnick | Executive Officer, Director | |
| Dan Watkins | Executive Officer, Director | |
| John Westwick | Director |
Other biotechnology companies in Maryland that filed recently
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
Every Form D from the week of Jun 3, 2024 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what AskY Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.